The New Biology of Lung Cancer: Changing Paradigms in Personalized Medicine

Physicians Education Resource
Archive
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Course Content
CME-certified satellite symposium, will inform participants of the emerging diversity of lung cancer and the implications for individualized therapy. The newfound importance of biomarkers in treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. Selected use of targeted agents, including EGFR and angiogenesis inhibitors, will be discussed, as will novel targets including EML4-ALK. Didactic lectures from lung cancer experts will...
Learning objectives, training objectives
Please see our websie for all the details www.cancerlearning.com
Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health
Notes
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/541
 

Enquiries and Registration:

Mr. Duane Fowler
 
Categories
Oncology
Languages
English
Fees
complimentary
Organizer contact info
3500 Maple Ave. Ste. 700
75219 Dallas
USA
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthCenter of ExcellenceEuropean Public Health Association (EUPHA)European Health Forum GasteinÄrzte der WeltCharité International AcademySwiss Tropical and Public Health InstituteHelix - Forschung & Beratung Wien

Facebook

Give us your professional opinion

Start survey

Start survey